On 14 November 2017, the Antimonopoly Committee of Ukraine (the "AMC") adopted a fining decision against a pharmaceutical producer and two of its Ukrainian distributors, which fundamentally changes the approaches to defining lawful market behavior in vertical relations. The decision unquestionably requires immediate attention of compliance officers of major international and Ukrainian companies.
By adopting its decision, the AMC established a precedent expanding competition law prohibitions on the market behavior previously considered as lawful. In particular, the AMC’s decision changes approaches to definition of the market power, qualification of misappropriate conduct within distribution agreements and discount systems. In particular, the following, formerly legal, practices may now fall under scrutiny of the AMC:
Notably, markets with insignificant presence of an undertaking were assessed by the AMC in the same manner as those on which such undertaking presumably had a market power.